相似文献
1
Identification of dihydropyridines that reduce cellular tau levels.
Chem Commun (Camb). 2011 Jan 7;47(1):529-31. doi: 10.1039/c0cc02253e. Epub 2010 Nov 16.
2
Optimization of diastereomeric dihydropyridines as antimalarials.
Eur J Med Chem. 2024 Sep 5;275:116599. doi: 10.1016/j.ejmech.2024.116599. Epub 2024 Jun 18.
3
Four-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents.
Med Chem. 2012 May;8(3):392-400. doi: 10.2174/1573406411208030392.
4
CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents.
Med Chem. 2012 May;8(3):372-83. doi: 10.2174/157340612800786598.
5
One-pot synthesis of 4,6-diaryl-2-oxo(imino)-1,2-dihydropyridine-3-carbonitrile; a New Scaffold for p38alpha MAP kinase inhibition.
J Comb Chem. 2010 Jul 12;12(4):559-65. doi: 10.1021/cc1000488.
6
Microwave-assisted combinatorial synthesis of hexa-substituted 1,4-dihydropyridines scaffolds using one-pot two-step multicomponent reaction followed by a S-alkylation.
J Comb Chem. 2008 May-Jun;10(3):436-41. doi: 10.1021/cc700194b. Epub 2008 Apr 16.
7
Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Eur J Med Chem. 2011 May;46(5):1564-71. doi: 10.1016/j.ejmech.2011.02.003. Epub 2011 Mar 5.
8
Synthesis of new tripodal Hantzsch 1,4-dihydropyridines under solvent-free condition and their conversion to the corresponding tripodal pyridines.
Mol Divers. 2010 Nov;14(4):809-13. doi: 10.1007/s11030-009-9171-7. Epub 2009 Jul 4.
9
Multicomponent reactions in crop protection chemistry.
Bioorg Med Chem. 2020 May 15;28(10):115471. doi: 10.1016/j.bmc.2020.115471. Epub 2020 Mar 31.
10
Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
Chem Biol Drug Des. 2015 Sep;86(3):370-7. doi: 10.1111/cbdd.12502. Epub 2015 Jan 9.
引用本文的文献
1
Water compatible silica supported iron trifluoroacetate and trichloroacetate: as prominent and recyclable Lewis acid catalysts for solvent-free green synthesis of hexahydroquinoline-3-carboxamides.
RSC Adv. 2023 Aug 4;13(34):23431-23448. doi: 10.1039/d3ra03542e.
2
1,4-Dihydropyridine: synthetic advances, medicinal and insecticidal properties.
RSC Adv. 2022 Oct 12;12(45):29253-29290. doi: 10.1039/d2ra04589c. eCollection 2022 Oct 11.
3
Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels.
Bioorg Med Chem Lett. 2021 Jun 1;41:128025. doi: 10.1016/j.bmcl.2021.128025. Epub 2021 Apr 9.
4
Intercepted-Knoevenagel condensation for the synthesis of unsymmetrical fused-tricyclic 4-pyrans.
Tetrahedron. 2019 Oct 25;75(43). doi: 10.1016/j.tet.2019.130606. Epub 2019 Sep 17.
5
Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
J Mol Neurosci. 2018 Nov;66(3):356-368. doi: 10.1007/s12031-018-1174-3. Epub 2018 Sep 28.
6
Transcriptional Inhibitors Identified in a 160,000-Compound Small-Molecule DUX4 Viability Screen.
J Biomol Screen. 2016 Aug;21(7):680-8. doi: 10.1177/1087057116651868. Epub 2016 May 31.
7
Lanthanide and asymmetric catalyzed syntheses of sterically hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones.
Tetrahedron Lett. 2016 Jan 20;57(3):423-425. doi: 10.1016/j.tetlet.2015.12.038.
8
The molecular diversity scope of 1,3-indandione in organic synthesis.
Mol Divers. 2016 Feb;20(1):111-52. doi: 10.1007/s11030-015-9589-z. Epub 2015 May 10.
9
Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.
J Neurosci. 2014 Jul 9;34(28):9222-34. doi: 10.1523/JNEUROSCI.1132-14.2014.
10
Pharmacological tuning of heat shock protein 70 modulates polyglutamine toxicity and aggregation.
ACS Chem Biol. 2012 Sep 21;7(9):1556-64. doi: 10.1021/cb300166p. Epub 2012 Jun 22.
本文引用的文献
1
Chemical manipulation of hsp70 ATPase activity regulates tau stability.
J Neurosci. 2009 Sep 30;29(39):12079-88. doi: 10.1523/JNEUROSCI.3345-09.2009.
2
Enantioselective organocatalytic Hantzsch synthesis of polyhydroquinolines.
Org Lett. 2009 Jul 16;11(14):2957-9. doi: 10.1021/ol901114f.
3
Chaperone signalling complexes in Alzheimer's disease.
J Cell Mol Med. 2009 Apr;13(4):619-30. doi: 10.1111/j.1582-4934.2008.00557.x.
4
Synthesis of new acridines and hydrazones derived from cyclic beta-diketone for cytotoxic and antiviral evaluation.
Eur J Med Chem. 2009 Sep;44(9):3680-6. doi: 10.1016/j.ejmech.2009.04.001. Epub 2009 Apr 8.
5
Tau pathophysiology in neurodegeneration: a tangled issue.
Trends Neurosci. 2009 Mar;32(3):150-9. doi: 10.1016/j.tins.2008.11.007. Epub 2009 Jan 21.
6
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology.
J Neurosci. 2008 Nov 19;28(47):12163-75. doi: 10.1523/JNEUROSCI.2464-08.2008.
7
Tau mutations in neurodegenerative diseases.
J Biol Chem. 2009 Mar 6;284(10):6021-5. doi: 10.1074/jbc.R800013200. Epub 2008 Oct 22.
8
The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
Biochemistry. 2008 Oct 7;47(40):10526-39. doi: 10.1021/bi800783d. Epub 2008 Sep 11.
9
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases.
Nat Rev Drug Discov. 2007 Jun;6(6):464-79. doi: 10.1038/nrd2111.
10
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
J Clin Invest. 2007 Mar;117(3):648-58. doi: 10.1172/JCI29715. Epub 2007 Feb 15.
Zotero 插件